Gaoxiang Wang

3.0k total citations
64 papers, 442 citations indexed

About

Gaoxiang Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Gaoxiang Wang has authored 64 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 14 papers in Molecular Biology. Recurrent topics in Gaoxiang Wang's work include CAR-T cell therapy research (16 papers), Esophageal Cancer Research and Treatment (6 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Gaoxiang Wang is often cited by papers focused on CAR-T cell therapy research (16 papers), Esophageal Cancer Research and Treatment (6 papers) and Lung Cancer Diagnosis and Treatment (6 papers). Gaoxiang Wang collaborates with scholars based in China, United States and France. Gaoxiang Wang's co-authors include Jianfeng Zhou, Yang Cao, Jiaqi Tan, Yicheng Zhang, Liting Chen, Pan Zhou, Liang Huang, Cheng Sun, Yang Zhang and Ki-Hee Song and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Gaoxiang Wang

55 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gaoxiang Wang China 13 162 148 70 68 55 64 442
Anja Germann Germany 13 266 1.6× 116 0.8× 35 0.5× 123 1.8× 40 0.7× 20 491
Margherita Passariello Italy 14 219 1.4× 305 2.1× 40 0.6× 165 2.4× 56 1.0× 32 589
Alexander Schultze Germany 10 187 1.2× 111 0.8× 32 0.5× 50 0.7× 100 1.8× 19 424
Jeonghwan Youk South Korea 12 240 1.5× 162 1.1× 91 1.3× 34 0.5× 40 0.7× 40 506
Litian Yu China 12 176 1.1× 119 0.8× 36 0.5× 40 0.6× 41 0.7× 31 590
Dionisia Quiroga United States 9 150 0.9× 192 1.3× 74 1.1× 188 2.8× 17 0.3× 33 500
Gizette Sperinde United States 8 201 1.2× 78 0.5× 41 0.6× 146 2.1× 39 0.7× 24 458
Zhinan Xia China 9 177 1.1× 155 1.0× 59 0.8× 257 3.8× 18 0.3× 22 526

Countries citing papers authored by Gaoxiang Wang

Since Specialization
Citations

This map shows the geographic impact of Gaoxiang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gaoxiang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gaoxiang Wang more than expected).

Fields of papers citing papers by Gaoxiang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gaoxiang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gaoxiang Wang. The network helps show where Gaoxiang Wang may publish in the future.

Co-authorship network of co-authors of Gaoxiang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Gaoxiang Wang. A scholar is included among the top collaborators of Gaoxiang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gaoxiang Wang. Gaoxiang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Gaoxiang, Lijun Jiang, Qiuxia Yu, et al.. (2025). Be cautious to adopt a second CAR T-cell infusion after failure of CD19/CD22 cocktail CAR T-cell therapy in relapsed/refractory B-NHL. Cancer Immunology Immunotherapy. 74(5). 156–156.
2.
Huang, Jingtao, et al.. (2025). Allogeneic transplantation in adverse-risk acute myeloid leukemia: Challenges, strategies, and future directions. Chinese Journal of Cancer Research. 37(5). 718–736.
4.
Wang, Jue, et al.. (2024). Case report: Acute HHV6B encephalitis/myelitis post CAR-T cell therapy in patients with relapsed/refractory aggressive B-cell lymphoma. Frontiers in Neurology. 15. 1334000–1334000. 9 indexed citations
6.
Zhao, Qinying, et al.. (2023). PANoptosis-related long non-coding RNA signature to predict the prognosis and immune landscapes of pancreatic adenocarcinoma. Biochemistry and Biophysics Reports. 37. 101600–101600. 11 indexed citations
7.
Zhang, Shuangshuang, Yi‐Wen Huang, Gaoxiang Wang, et al.. (2023). Identification of a cancer associated fibroblasts-related index to predict prognosis and immune landscape in ovarian cancer. Scientific Reports. 13(1). 21565–21565. 10 indexed citations
8.
Zhang, Yuanyuan, Tong Ge, Meijuan Huang, et al.. (2023). Extracellular Vesicles Expressing CD19 Antigen Improve Expansion and Efficacy of CD19-Targeted CAR-T Cells. International Journal of Nanomedicine. Volume 18. 49–63. 10 indexed citations
9.
Wang, Na, Gaoxiang Wang, Liang Huang, et al.. (2022). CAR19/22 T cell cocktail therapy for B-ALL relapsed after allogeneic hematopoietic stem cell transplantation. Cytotherapy. 24(8). 841–849. 14 indexed citations
10.
Yu, Qiuxia, et al.. (2022). Primary Testicular and Cutaneous Philadelphia Chromosome Positive B-Cell Lymphoblastic Lymphoma: A Rare Case and Review. Cancer Management and Research. Volume 14. 1507–1514.
11.
Wang, Gaoxiang, et al.. (2022). Sequential pulmonary resections by uniportal video-assisted thoracic surgery for bilateral multiple pulmonary nodules. Frontiers in Oncology. 12. 961812–961812. 3 indexed citations
12.
Zhao, Qinying, Yue Wu, Gaoxiang Wang, et al.. (2022). Construction of a cancer-associated fibroblasts-related long non-coding RNA signature to predict prognosis and immune landscape in pancreatic adenocarcinoma. Frontiers in Genetics. 13. 989719–989719. 17 indexed citations
13.
Jiang, Haili, Yue Wu, Gaoxiang Wang, et al.. (2022). Role of ARRB1 in prognosis and immunotherapy: A Pan-Cancer analysis. Frontiers in Molecular Biosciences. 9. 1001225–1001225. 9 indexed citations
14.
Xie, Xiaowei, Xuelian Cheng, Gaoxiang Wang, et al.. (2021). Single-cell transcriptomes of peripheral blood cells indicate and elucidate severity of COVID-19. Science China Life Sciences. 64(10). 1634–1644. 11 indexed citations
15.
Luo, Hui, Wenbing Liu, Gaoxiang Wang, et al.. (2021). Germline variants in UNC13D and AP3B1 are enriched in COVID-19 patients experiencing severe cytokine storms. European Journal of Human Genetics. 29(8). 1312–1315. 24 indexed citations
16.
Wang, Gaoxiang, et al.. (2021). Evolution of Intelligent Feeding System for Aquaculture: A Review. 392–397. 3 indexed citations
18.
Wang, Gaoxiang, et al.. (2020). Long‐term survival analysis of patients with non‐small cell lung cancer complicated with type 2 diabetes mellitus. Thoracic Cancer. 11(5). 1309–1318. 4 indexed citations
19.
Zhou, Xiaoxi, Gaoxiang Wang, Liting Chen, et al.. (2020). Clinical characteristics of hematological patients concomitant with COVID‐19. Cancer Science. 111(9). 3379–3385. 12 indexed citations
20.
Huang, Liang, Na Wang, Yang Cao, et al.. (2018). CAR22/19 Cocktail Therapy for Patients with Refractory/Relapsed B-Cell Malignancies. Blood. 132(Supplement 1). 1408–1408. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026